USPTO Examiner WENG KAI H - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19071139WEARABLE EYE IRRIGATION SYSTEMMarch 2025May 2025Allow200NoNo
18965473FLUID TRANSFER DEVICEDecember 2024February 2025Allow300NoNo
18917987ADIPOSE TISSUE SEPARATION DEVICE WITH PRESSURE EQUALIZATIONOctober 2024August 2025Allow1010YesNo
18746471STENT DELIVERY SYSTEM HAVING RETENTION STRUCTUREJune 2024February 2025Allow700NoNo
18670034DEVICE FOR APPLYING LIQUID MEDICAL SUBSTANCESMay 2024October 2025Allow1720NoNo
18662078METHOD AND DEVICE FOR SIMULTANEOUSLY DOCUMENTING AND TREATING TENSION PNEUMOTHORAX AND/OR HEMOTHORAXMay 2024May 2025Allow1210NoNo
18632872TISSUE PROCESSING APPARATUS AND METHOD FOR PROCESSING ADIPOSE TISSUEApril 2024May 2025Abandon1410NoNo
18606266PYLORIC ANCHORS AND METHODS FOR INTESTINAL BYPASS SLEEVESMarch 2024June 2025Abandon1510NoNo
18443647SYSTEMS AND METHODS FOR DRAINING CEREBROSPINAL FLUIDFebruary 2024January 2026Allow2320NoNo
18410649METHOD FOR TEMPORARILY INTERRUPTING AN EXTRACORPOREAL BLOOD TREATMENT, CONTROL DEVICE AND BLOOD TREATMENT APPARATUSJanuary 2024November 2025Allow2220YesNo
18394425NEGATIVE PRESSURE WOUND THERAPY DEVICE ACTIVATION AND CONTROLDecember 2023February 2026Allow2500NoNo
18538591SHUNT SYSTEM, SHUNT AND METHOD FOR TREATING AN OCULAR DISORDERDecember 2023October 2025Abandon2210NoNo
18537989LOW PROFILE DISTRIBUTION COMPONENTS FOR WOUND THERAPYDecember 2023February 2025Allow1400NoNo
18533946SYSTEMS AND METHODS FOR ASPIRATING FROM A BODY LUMENDecember 2023October 2025Abandon2220NoNo
18526402PERCUTANEOUS ACCESS PATHWAY SYSTEM AND METHODDecember 2023November 2024Allow1100NoNo
18523750ADJUSTABLE SHUNTING SYSTEMS WITH PLATE ASSEMBLIES, AND ASSOCIATED SYSTEMS AND METHODSNovember 2023October 2025Allow2201NoNo
18514860PRESSURE-REGULATING VIAL ADAPTORSNovember 2023August 2025Allow2110YesNo
18511584AN INDWELLING CATHETER SYSTEMNovember 2023January 2026Allow2600NoNo
18510399ASPIRATION PUMP FOR REMOVAL OF FLUIDS, BLOOD CLOTS AND OTHER MATERIALS FROM HUMAN BODYNovember 2023April 2024Allow510YesNo
18510516VIAL ASSEMBLY WITH LUER FITTINGNovember 2023August 2024Allow900NoNo
18388200Negative Pressure Therapy Systems and SpongesNovember 2023August 2024Allow1010NoNo
18495829WEARABLE ARTICLE COMPRISING A LAMINATEOctober 2023February 2026Allow2700NoNo
18384326Blood OxygenatorOctober 2023October 2025Allow2400NoNo
18486488SURGICAL DEVICE FOR CEREBRAL HERNIATIONOctober 2023October 2025Allow2400NoNo
18483509SYSTEMS AND METHODS FOR TREATING HYDROCEPHALUSOctober 2023October 2025Allow2400NoNo
18376389METHODS AND ADAPTERS FOR MIXING PHARMACEUTICAL COMPLEXESOctober 2023February 2026Allow2900NoNo
18280122A TAMPER PROOF LUER LOCK CONNECTOR AND A VALVE ARRANGEMENT FOR AN ADAPTORSeptember 2023June 2024Allow1000NoNo
18241728TAMPER PROOF LUER LOCK CONNECTOR AND A VALVE ARRANGEMENT FOR AN ADAPTORSeptember 2023July 2025Allow2240NoNo
18363981SECURED MEDICATION TRANSFER SYSTEMAugust 2023April 2025Allow2020NoNo
18359838APPARATUS AND METHODS FOR TREATING EXCESS INTRAOCULAR FLUIDJuly 2023December 2025Allow2830YesNo
18225923PACKAGING ASSEMBLY FOR STORING TISSUE AND CELLULAR MATERIALJuly 2023January 2026Allow3011NoNo
18221362Systems and Methods for Administering Fluid CompositionsJuly 2023October 2025Allow2700NoNo
18214496ANTI-CLOG SUCTION TIP APPARATUS AND METHODSJune 2023January 2026Allow3110NoNo
18269070NOVEL AQUEOUS HUMOR DRAINAGE DEVICE FOR CONTROLLING INTRAOCULAR PRESSUREJune 2023February 2026Abandon3110NoNo
18141685DEVICE FOR PROCESSING TISSUEMay 2023August 2025Abandon2710NoNo
18140652HEART HELP DEVICE, SYSTEM, AND METHODApril 2023August 2024Allow1610NoNo
18140050SYSTEMS AND METHODS FOR DRAINING CEREBROSPINAL FLUIDApril 2023February 2024Allow920YesNo
18191516Drainage Catheter System Including a HubMarch 2023October 2025Abandon3120NoNo
18245839SYSTEMS AND METHODS FOR THE PREPARATION OF FLUIDS FOR BIOPROCESS AND PHARMACEUTICAL APPLICATIONSMarch 2023November 2025Allow3210NoNo
18117570SYSTEMS AND METHODS FOR TREATING PULMONARY EDEMAMarch 2023December 2025Allow3420NoNo
18116908COLLECTION BOTTLE WITH INTEGRATED CAP, HANDLE, AND SHIELD FEATURESMarch 2023August 2025Allow2910YesNo
18177261Catheter Device Including a ConnectorMarch 2023August 2025Allow3020NoNo
18110735Flow Indwelling Urinary CatheterFebruary 2023March 2024Abandon1310NoNo
18156822INTRAOCULAR SHUNT IMPLANTATION METHODS AND DEVICESJanuary 2023October 2024Abandon2010NoNo
18011027CLOSED SYSTEM TRANSFER DEVICEDecember 2022April 2025Allow2800NoNo
18075532VIAL ADAPTOR ASSEMBLY FOR A CLOSED FLUID TRANSFER SYSTEMDecember 2022February 2026Allow3830NoNo
17988159ELECTROOSMOTIC PUMPNovember 2022October 2025Abandon3511NoNo
17985751STENT DELIVERY SYSTEM HAVING RETENTION STRUCTURENovember 2022March 2024Allow1600NoNo
18052650OSTOMY OUTPUT DIVERSION DEVICENovember 2022April 2025Allow2900NoNo
18048494SYSTEMS AND METHODS FOR PRODUCING MIXTURESOctober 2022March 2026Allow4120NoNo
17937574EXHAUST COLLECTION BAG FOR CRYOGENIC TREATMENTOctober 2022September 2024Allow2400NoNo
17957739WOUND THERAPY SYSTEM WITH INTERNAL ALTERNATING ORIFICESeptember 2022June 2025Allow3311NoNo
17950614ABSORBENT ARTICLE WITH BODY CONFORMING STRUCTURESeptember 2022December 2024Allow2620NoNo
17943598Waste Collection System With Controllers For Regulating Levels Of Vacuum Drawn On A Waste ContainerSeptember 2022October 2024Allow2500YesNo
17902373Medication Dose Preparation and Transfer SystemSeptember 2022March 2025Allow3110NoNo
17889673SYSTEM AND METHOD FOR DRAINING CEREBROSPINAL FLUID IN HYDROCEPHALUS PATIENTSAugust 2022June 2024Allow2210NoNo
17877358URETHRAL CATHETERS AND METHODS FOR FACILITATED INTRODUCTION INTO THE URINARY TRACTJuly 2022October 2024Abandon2610NoNo
17873877WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATIONJuly 2022April 2025Allow3321YesNo
17814548METHOD OF OPERATION UTILIZING VENTING FOR PROCESSING OF BLOOD TO REMOVE PATHOGEN CELLS THEREINJuly 2022September 2025Allow3810NoNo
17871868NEGATIVE PRESSURE WOUND THERAPY APPARATUSES AND METHODS FOR USING THE SAMEJuly 2022May 2024Allow2200NoNo
17869265OPHTHALMIC SYSTEM FOR SUSTAINED RELEASE OF DRUG TO EYEJuly 2022November 2025Abandon4010NoNo
17851562ANTIMICROBIAL LIGHT-EMITTING OROPHARYNGEAL DEVICE FOR VENTILATOR-ASSOCIATED PNEUMONIAJune 2022August 2023Abandon1350NoNo
17843139METHOD AND DEVICE FOR SIMULTANEOUSLY DOCUMENTING AND TREATING TENSION PNEUMOTHORAX AND/OR HEMOTHORAXJune 2022February 2024Allow2000NoNo
17745544SYSTEMS, METHODS AND HANDHELD PULSATILE ASPIRATION AND INJECTION DEVICESMay 2022March 2025Abandon3411NoNo
17774310ADJUSTABLE SHUNTING SYSTEMS WITH PLATE ASSEMBLIES, AND ASSOCIATED SYSTEMS AND METHODSMay 2022August 2023Allow1601NoNo
17713940METHOD AND APPARATUS FOR IDENTIFYING DISRUPTION OF A FLUID CONNECTION BETWEEN AN EXTRACORPOREAL CIRCUIT AND A PATIENT CIRCULATORY SYSTEMApril 2022September 2025Allow4120NoNo
17670215FLUID DELIVERY ALIGNMENT SYSTEMFebruary 2022January 2025Allow3520NoNo
17668480MEMBRANE AND DEVICE FOR TREATING RESTLESS LEG SYNDROMEFebruary 2022April 2024Allow2610NoNo
17590357Protector Housing Plastic Spike with Flash Intended for DVO Last Drop ExtractionFebruary 2022November 2024Allow3310NoNo
17580865TISSUE PROCESSING APPARATUS AND METHOD FOR PROCESSING ADIPOSE TISSUEJanuary 2022May 2024Abandon2810NoNo
17580448HANDHELD FILAMENT EXTENSION ATOMIZER FOR PRECISION DELIVERY OF DRUGS AND THERAPEUTICSJanuary 2022June 2025Allow4110NoNo
17645520BALLOON CATHETERDecember 2021February 2024Allow2610NoNo
17555688Manifold For A Medical Waste Collection SystemDecember 2021March 2025Allow3900NoNo
17555195METHOD AND APPARATUS FOR PROVIDING NEGATIVE PRESSURE TO A NEGATIVE PRESSURE WOUND THERAPY BANDAGEDecember 2021July 2024Allow3120YesNo
17549127Lipoaspirate ProcessingDecember 2021August 2022Allow910YesNo
17617072FLUID TRANSFER SYSTEM AND COMPONENTS THEREFORDecember 2021March 2025Abandon4060YesNo
17615717SUCTION BOTTLE FOR THROMBUS ASPIRATOR AND THROMBUS ASPIRATORDecember 2021August 2024Allow3220NoNo
17490395CLIP FOR URINARY DRAINAGE SYSTEMSeptember 2021December 2021Allow300YesNo
17489660Bone Dust Collection Cap and Plunger AssemblySeptember 2021March 2022Allow501NoNo
17478995Removal Of Microbubbles Through Drip Chamber Nucleation SitesSeptember 2021April 2024Allow3120NoNo
17444541TEMPERATURE MANAGEMENT SYSTEM FOR PATIENTS DURING STATIONARY AND MOBILE ECLS/ECMO THERAPYAugust 2021August 2025Allow4820YesNo
17376554MEDICAL SYSTEM INCLUDING TWO ACCESS PORTSJuly 2021October 2025Allow5130YesNo
17375040OSTOMY APPLIANCE HAVING AN ALARM FOR SENSED MOISTUREJuly 2021June 2025Abandon4721NoNo
17370965Reduced-Pressure, Tunnel-Wound Dressings, Systems, And MethodsJuly 2021August 2024Abandon3701NoNo
17418861VALVE FOR PERMANENT IMPLANTATION, IN PARTICULAR FOR TREATMENT OF NORMAL PRESSURE HYDROCEPHALUSJune 2021February 2025Allow4311NoNo
17353132DEVICE FOR APPLYING LIQUID MEDICAL SUBSTANCESJune 2021February 2024Allow3210NoNo
17343066CANALICULAR PLUG, METHOD AND KIT FOR TREATING DRY EYEJune 2021November 2021Allow510NoNo
17326081SYSTEMS AND METHODS FOR DELIVERY OF A THERAPEUTIC AGENTMay 2021May 2024Abandon3610NoNo
17321296LOW POWER, CHEMICALLY AMPLIFIED, ELECTRICALLY REMOVABLE BARRIERMay 2021October 2023Allow2900NoNo
17314129Tubing Connection Adaptor SystemMay 2021March 2025Abandon4620NoNo
17307279Blood pump and oxygenator combination.May 2021December 2024Abandon4321NoNo
17233765APPLICATORS, COMPOSITIONS AND METHODS FOR CLEANSING AN OCULAR AREAApril 2021February 2025Abandon4620NoNo
17228901METHOD FOR REDUCING BIOFILM FORMATIONApril 2021August 2023Allow2810NoNo
17226839SYSTEMS AND METHODS FOR COUPLING AND DECOUPLING A CATHETERApril 2021October 2024Allow4211NoNo
17280346DRAINAGE DEVICE WITH PRESSURE RELIEF VALVEMarch 2021March 2023Abandon2320NoNo
17199532ACUTE GLAUCOMA DEVICEMarch 2021April 2024Allow3721NoNo
17193962SYSTEMS AND METHODS FOR ASPIRATING FROM A BODY LUMENMarch 2021August 2023Allow2910NoNo
17179116USING WICKING MATERIAL TO COLLECT LIQUID FOR TRANSPORTFebruary 2021September 2024Allow4330YesNo
17176580METHOD OF USING A CATHETER WITH A DEDICATED FLUSHING PORTFebruary 2021November 2023Abandon3210NoNo
17172262Polychromatic Phototherapy Device and MethodFebruary 2021May 2024Allow3911YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WENG, KAI H.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
1
(25.0%)
Examiner Reversed
3
(75.0%)
Reversal Percentile
90.0%
Higher than average

What This Means

With a 75.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
7
(46.7%)
Not Allowed After Appeal Filing
8
(53.3%)
Filing Benefit Percentile
75.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 46.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner WENG, KAI H - Prosecution Strategy Guide

Executive Summary

Examiner WENG, KAI H works in Art Unit 3781 and has examined 335 patent applications in our dataset. With an allowance rate of 77.0%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner WENG, KAI H's allowance rate of 77.0% places them in the 44% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by WENG, KAI H receive 2.06 office actions before reaching final disposition. This places the examiner in the 54% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by WENG, KAI H is 36 months. This places the examiner in the 37% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +13.9% benefit to allowance rate for applications examined by WENG, KAI H. This interview benefit is in the 52% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 24.1% of applications are subsequently allowed. This success rate is in the 35% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.2% of cases where such amendments are filed. This entry rate is in the 21% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 40.0% are granted (fully or in part). This grant rate is in the 31% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.